INDIANA– A nationwide recall for more than 14,000 packs of Safetussin’s Max Strength Multi-Symptom Cough, Cold and Flu tablets due to a potential risk of child poisoning. The U.S. Consumer Product Safety Commission (CPSC) announced the recall on Thursday, stating that the product’s packaging does not meet federal safety standards for child-resistant packaging.
The recalled Safetussin tablets are in blister packs that can be easily pushed through a piece of foil. If children swallow the contents, there is a significant risk of poisoning. The CPSC reports that approximately 14,250 packs are affected by this recall.
As of Thursday, authorities stated that no injuries or incidents related to the packaging issue had been reported.
The recall specifically involves Safetussin’s Max Strength Multi-Symptom Cough, Cold & Flu 24-count caplet blister packs. These packs are labeled with “Multi-Symptom,” “Cough, Cold & Flu,” and “Safe for adults with High Blood Pressure and diabetes.” The product is sold in blue, orange, and red cardboard boxes, with each box typically retailing for around $11.
According to the CPSC, the recalled packs were available for purchase at various retailers nationwide between July 2024 and March 2025, including H-E-B, Harris-Teeter, and other regional grocery stores, as well as independently owned pharmacies.
The recalled medicine was manufactured in India and distributed by Kramer Laboratories, based in Bridgewater, New Jersey, according to information from Safetussin.
Consumers who have purchased the recalled Safetussin product are urged to immediately secure it out of the sight and reach of children.
Kramer Laboratories advises consumers to contact them for information on how to properly return or dispose of the recalled product. They can be reached by phone at 800-824-4894, Monday through Friday, between 8:00 a.m. and 5:00 p.m. Eastern Time. Consumers can also contact the company via email at kramerlabs@emersongroup.com or visit the Safetussin website at safetussin.com/recall for further details.
This recall underscores the importance of child-resistant packaging for over-the-counter medications and reminds consumers to take precautions to prevent accidental poisoning.
